34 results
8-K
EX-99.1
ZOM
Zomedica Corp
4 Apr 24
Results of Operations and Financial Condition
12:10pm
products. We anticipate that R&D costs will increase as we maintain and enhance our current product lines and continue to develop new products
DEFA14A
ZOM
Zomedica Corp
24 Jan 24
Additional proxy soliciting materials
1:38pm
built the infrastructure for R&D and manufacturing while producing very strong margins. And we’ve got a bit more than $100 million dollars in liquidity
8-K
EX-99.1
ZOM
Zomedica Corp
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
development for the TRUFORMA platform. This acquisition will also allow us to avoid future operating and capital expenses incurred by building R&D
8-K
EX-99.1
j8hxph7qdsxpcj2p4
26 Feb 21
Zomedica Corp. Announces Year End 2020 Financial Results
4:20pm
424B3
oirp1m2m no8
26 Oct 20
Prospectus supplement
9:21am
S-4/A
z0tqh9 n7
22 Oct 20
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
5kj6e8zeazsvwd1
9 Oct 20
Registration of securities issued in business combination transactions
1:57pm
8-K
EX-99.1
xkgst
26 Feb 20
Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results
5:27pm
8-K
EX-99.1
wf0y w8aht0pnoaica9
10 May 19
Zomedica Announces First Quarter 2019 Financial Results
5:28pm